Wednesday, 9 January 2019

Senolytic Therapeutics kicks off Q1 2019 with high-profile speaking events

(Life Biosciences) Senolytic Therapeutics, an innovator in senescent cell research and one of the first Daughter companies to join the hub-and-spoke business model of Life Biosciences, is being recognized by leading institutions for its work to combat aging and age-related decline.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2H4CGA9

No comments:

Post a Comment